Allurion stock surges 40% on U.S. FDA approval

Allurion stock surges 40% on U.S. FDA approvalSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com

Allurion stock surges 40% on U.S. FDA approvalSource: Investing.com
This e-commerce stock could be among biggest beneficiaries of the tariff rulingSource: Investing.com

Our Bond stock jumps on $250,000 pharma contract dealSource: Investing.com

Dominion Energy forecasts annual profit below estimates, raises spending planSource: Reuters

TOP Ships stock surges on $679M tanker dealSource: Investing.com

FTC Solar Shares Rise on Three-Year Supply Deal With South African FirmSource: Investing.com

Enhabit shares jump 23% as Kinderhook agrees to $1.1 billion buyoutSource: Investing.com

Fortune Brands stock faces investor push to replace incoming CEOSource: Investing.com

InMode stock falls after takeover process endsSource: Investing.com

Hamborner REIT adjusts portfolio strategy, forecasts funds from operations of €38-42 millionSource: Investing.com